A SmartOrg® webinar with Julia Reznick, TEVA Pharmaceuticals
(Originally presented April 25, 2017)
Julia Reznick is the VP of Global Portfolio and Pipeline for Teva Global Specialty Medicine, a division of the Top Ten global pharmaceutical company. In 2010, Teva faced the imminent expiration of patent protection on its flagship product. They looked to portfolio management as the way to focus their development efforts and create sustainable growth to replace that product.
In this webinar, Portfolio Management Evolution, Julia tells how Teva successfully made the transition even as the company undertook a major acquisition. She explains why she describes portfolio management as the “spinal cord” of an organization, coordinating the planning and execution by all of its parts to achieve the organization’s strategic goals. She describes the role SmartOrg®played in Teva’s portfolio management success.
She also answers audience questions.